Archive for October 2026

Spearhead Bio announced today that it closed an oversubscribed $1.62M seed round SAFE investment to advance the development and implementation of its patented TAHITI genome engineering technology. Spearhead Bio was founded in 2024 by Donald Danforth Plant Science Center Principal Investigator Dr. Keith Slotkin. TAHITI is a breakthrough platform that opens the door for the use of…